Results 21 to 30 of about 100,497 (232)

Características e evolução clínica da retinite por citomegalovírus em pacientes com AIDS na era da terapia antirretroviral potente [PDF]

, 2010
PURPOSE: To describe the features and outcomes of patients with AIDS-related cytomegalovirus retinitis after highly active antiretroviral therapy availability.
Arantes, Tiago Eugênio Faria E, Garcia, Claudio Renato, Muccioli, Cristina, Saraceno, Janaína Jamile Ferreira   +3 more
core   +2 more sources

Duration of Highly Active Antiretroviral Therapy Regimens [PDF]

Clinical Infectious Diseases, 2003
The median duration of highly active antiretroviral therapy (HAART) regimens was reported to be 11.8 months in one US study, but that study included both treatment-experienced and treatment-naive patients. The duration of initial HAART regimens for treatment-naive patients alone has not been reported.
Ray Y, Chen, Andrew O, Westfall, Michael J, Mugavero, Gretchen A, Cloud, James L, Raper, Ashlee G, Chatham, Edward P, Acosta, Kelly H, Taylor, Jerome, Carter, Michael S, Saag   +9 more
openaire   +2 more sources

HAART (Highly Active Anti-Retroviral Therapy) : An overview

Journal of Marine Medical Society, 2014
Highly Active Anti - Retroviral Therapy (HAART) is a triple combination of ART drugs and is a n effective tool to control disease progression in HIV disease.
Praful Pande, Vivek Hande
doaj   +1 more source

Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries [PDF]

, 2009
BACKGROUND: In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretroviral therapy should be evaluated.
Arnaud Fontanet, Bagchi, Bisson, Bonard, Bonnet, Calmy, Christine Genevier, Diggle, Elisabeth Szumilin, Erikstrup, Etard, Ferradini, Ferradini, Gilks, Harries, Ivers, Jerene, Laurent Ferradini, Madec, Malvy, Mar Pujades, Paton, Saghayam, San Lio, Severe, Shetty, Shikuma, Silva, Spacek, Stringer, Suna Balkan, Tang, Van Damme, Yoann Madec   +33 more
core   +3 more sources

Antiretroviral agents against human immunodeficiency virus

DST, 2022
Introduction: Since its discovery in the 1980s, the human immunodeficiency virus (HIV) has been the target of many studies. Nowadays, estimates show that 36.7 million people are infected with HIV worldwide.
Ingrid Barcelos de Oliveira, Claudio Cesar Cirne Santos, Izabel Christina Nunes de Palmer Paixão, Caroline de Souza Barros, Rosa Teixeira Pinho   +4 more
doaj  

Daily Dosing of Highly Active Antiretroviral Therapy [PDF]

Clinical Infectious Diseases, 2002
Complex treatment schedules for human immunodeficiency virus (HIV) disease, which can have a high pill burden and can include multiple daily doses, in addition to the adverse effects that the medications can cause, may reduce patient adherence to therapy. Reduced adherence prevents achievement of the desired goal of full suppression of HIV replication,
Keith A, Rosenbach, Robert, Allison, Jeffrey P, Nadler   +2 more
openaire   +2 more sources

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. [PDF]

, 2007
BACKGROUND: HAART efficacy was evaluated in a real-life setting in Phnom Penh (Médecins Sans Frontières programme) among severely immuno-compromised patients.
Akileswaran, Babiker, Badri, Braitstein, Calmy, Carr, Coetzee, Cozzi-Lepri, Dragsted, Egger, Ferradini, French, Furber, Hirsch, Ivers, Kaufmann, Keiser, Laurent, Lawn, Le Moing, Mahajan, Matthews, Mocroft, Pean, Ratnam, Severe, Shetty, Smit, Smith, Sungkanuparph, van Leth   +30 more
core   +3 more sources

Excess mortality and associated factors among people living with HIV initiating highly active antiretroviral therapy in Luzhou, China 2006–2020

BMC Infectious Diseases, 2023
Background To estimate crude mortality, excess mortality, and standardized mortality rates (SMR) among people living with HIV (PLHIV) initiating highly active antiretroviral therapy (HAART) in Luzhou, China 2006–2020, and assess associated factors ...
Dandan Niu, Ticheng Xiao, Yuanyi Chen, Houlin Tang, Fangfang Chen, Chang Cai, Qianqian Qin, Decai Zhao, Yichen Jin, Shi Wang, Yushan Hou, Zhen Lu, Luoyao Yang, Hong Liu, Dongqin Xie, Huachun Zou, Fan Lyu   +16 more
doaj   +1 more source

Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection [PDF]

, 2003
Liver-related mortality is an increasing problem in human immunodeficiency virus (HIV)/hepatitis B virus (HBV)-coinfected patients receiving highly active antiretroviral therapy (HAART).
Bertoletti, A, Gilson, RJ, Lascar, RM, Lopes, AR, Maini, MK   +4 more
core   +1 more source

Highly active antiretroviral therapy: Does it Sound toxic?

Journal of Pharmacy and Bioallied Sciences, 2011
Objective : The main objective of the current study is to monitor the auditory status in a group of adults with AIDS, receiving Highly Active Antiretroviral Therapy (HAART) (3TC -lamivudine, D4T - stavudine, and efavirenz) in a hospital outpatient clinic
Katijah Khoza-Shangase
doaj   +1 more source